In this piece, we’ll take a look at the 5 Best Breakout Stocks To Buy Now. For more such companies, go to 10 Best Breakout Stocks To Buy Now.
5. CDW Corporation (NASDAQ:CDW)
Number of Hedge Fund Holders: 34
CDW Corporation (NASDAQ:CDW) is an American technology solutions provider that offers a wide range of products and services to business, government, education, and healthcare customers. It is one of the largest technology solutions providers in the United States, with more than 260 sales locations across the country. CDW Corporation (NASDAQ:CDW)’s products and services include hardware, software, and services for enterprises, small and medium-sized businesses, and government and education customers.
On November 3, 2022, Jim Suva, an analyst at Citi, reduced his price target on CDW Corporation (NASDAQ:CDW) to $210 while keeping a Buy rating on the stock. According to the analyst, the company has continued to boost shareholder value despite the persisting supply chain restrictions and declining growth in PC segment.
At the end of Q3 2022, 34 hedge funds in Insider Monkey’s database were bullish on CDW Corporation (NASDAQ:CDW) at the end of the quarter. Select Equity Group remained the leading stakeholder of the company at the end of Q3 2022.
4. Willis Towers Watson Public Limited Company (NASDAQ:WTW)
Number of Hedge Fund Holders: 42
Willis Towers Watson Public Limited Company (NASDAQ: WTW) is a global professional services company that provides consulting, technology, and solutions to a range of industries, including financial services, healthcare, and energy. Willis Towers Watson Public Limited Company (NASDAQ:WTW)’s products and services include consulting services in the areas of risk, human resources, and financial and actuarial services. The company is known for its expertise in risk management, human capital, and financial management and is a leading provider of consulting technology and solutions to a variety of industries around the world.
On December 15, 2022, Andrew Kligerman, an analyst at Credit Suisse, increased his price target on Willis Towers Watson Public Limited Company (NASDAQ:WTW) to $302 while keeping an Outperform rating on the stock. The meetings with the CEO and CFO of the company have reassured the analyst’s confidence around Willis Towers Watson Public Limited Company (NASDAQ:WTW) achieving the 2024 target.
As per Insider Monkey’s database, 42 hedge funds owned stakes in Willis Towers Watson Public Limited Company (NASDAQ:WTW) at the end of the third quarter. First Eagle Investment Management remained the leading stakeholder of the company at the end of Q3 2022.
3. AstraZeneca PLC (NASDAQ:AZN)
Number of Hedge Fund Holders: 44
AstraZeneca PLC (NASDAQ:AZN) is a global biopharmaceutical company that develops and manufactures a range of innovative medicines and medical devices. The company operates in more than 100 countries and has a strong focus on research and development, with a number of research facilities around the world. AstraZeneca PLC (NASDAQ:AZN)’s products include prescription medications, over-the-counter products, and medical devices. The company’s products are used to treat a variety of conditions, including cancer, cardiovascular disease, respiratory illness, and infections.
On December 15, 2022, Emmanuel Papadakis, an analyst at Deutsche Bank, increased his price target on AstraZeneca PLC (NASDAQ:AZN) to £13,000 while keeping a Buy rating on the stock. The company’s third-quarter revenue stood at $10.98 billion, beating market expectations by $133.51 million. Its Normalized EPS was reported at $0.84, beating market expectations by $0.09.
44 hedge funds are currently bullish on AstraZeneca PLC (NASDAQ:AZN) as per Insider Monkey’s database. GQG Partners had the leading stake in the company at the end of Q3 2022.
2. American International Group, Inc. (NYSE:AIG)
Number of Hedge Fund Holders: 48
American International Group, Inc. (NYSE:AIG) is a global financial services company that provides insurance, asset management, and other financial products and services to customers around the world. American International Group, Inc. (NYSE:AIG)’s products and services include a range of insurance products, including property and casualty, life and retirement, and financial lines insurance; asset management and investment products; and a range of other financial services.
On December 14, 2022, Mark Dwelle, an analyst at RBC Capital, increased his price target on American International Group, Inc. (NYSE:AIG) to $73 while keeping an Outperform rating on the stock. The analyst anticipates American International Group, Inc. (NYSE:AIG) to be among the few P&C insurers that will improve their margin in 2023.
As per Insider Monkey’s database, 48 hedge funds had stakes in American International Group, Inc. (NYSE:AIG) at the end of the third quarter. Harris Associates remained the leading stakeholder in the company at the end of Q3 2022.
1. Pfizer Inc. (NYSE:PFE)
Number of Hedge Fund Holders: 77
Pfizer Inc. (NYSE:PFE) is an American multinational pharmaceutical company that develops and manufactures a range of innovative medicines and vaccines. The company is headquartered in New York City and was founded in 1849. Pfizer Inc. (NYSE:PFE)’s products include a range of prescription medications, vaccines, and consumer healthcare products. The company’s products are used to treat a variety of conditions, including cardiovascular disease, oncology, and infectious diseases.
On December 13, 2022, Chris Shibutani, an analyst at Goldman Sachs, raised his price target on Pfizer Inc. (NYSE:PFE) to $60. The analyst also upgraded his rating on the stock to Buy from Neutral citing the company’s strong business development and acquisition efforts.
According to Insider Monkey’s database, 77 hedge funds held shares of the company at the end of the third quarter of 2022. AQR Capital Management was the most bullish fund on the company’s stock at the end of Q3 2022.
You can also take a look at 11 Best Medical Technology Stocks To Buy and 15 Best Affordable Stocks To Buy Now.
